Baker Institute for Animal Health

DEDICATED TO THE STUDY OF VETERINARY INFECTIOUS DISEASES, IMMUNOLOGY, CANCER, REPRODUCTION, GENOMICS AND EPIGENOMICS

Researchers explore promising treatment for MRSA ‘superbug’

      A new Cornell study has found the antimicrobial properties of certain stem cell proteins could offer a potential treatment to reduce infection in skin wounds.

Treating wounds with the secretion of a type of stem cell effectively reduced the viability of methicillin-resistant Staphylococcus aureus – better known as MRSA – according to a new study from researchers at the Baker Institute for Animal Health, part of the College of Veterinary Medicine (CVM). Moreover, the secretion stimulated the surrounding skin cells to build up a defense against the bacterial invader, the researchers found. The study appeared Sept. 16 in Stem Cells Translational Medicine.

Read the full article in the September 16, 2021 Cornell Chronicle

Photo provided: The equine ex vivo skin biofilm explant model with an image of skin explants in culture (left) and bacterial biofilms stained with Alcian Blue (upper right) and an anti-bacterial antibody (lower right) to show the presence of bacteria in the skin biofilm explant model.